Twist Bioscience (TWST) Total Current Liabilities (2018 - 2026)

Twist Bioscience (TWST) has reported Total Current Liabilities for 9 consecutive years, with $120.3 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Total Current Liabilities rose 38.11% year-over-year to $120.3 million in Q2 2026; TTM through Jun 2026 was $120.3 million, a 38.11% increase from a year earlier, with the FY2025 full-year figure at $91.4 million, up 28.73% from the prior year.
• Total Current Liabilities was $120.3 million for Q2 2026 at Twist Bioscience, roughly flat from $120.0 million in the prior quarter.
• Over five years, Total Current Liabilities peaked at $120.3 million in Q2 2026 and troughed at $65.2 million in Q4 2023.
• A 5-year average of $82.9 million and a median of $77.7 million in 2025 frame the typical range for Total Current Liabilities.
• Across the five-year window, Total Current Liabilities surged 109.27% in 2022 and retreated 22.2% in 2023, its largest moves.
• Over 5 years, Total Current Liabilities stood at $83.8 million in 2022, then declined by 22.2% to $65.2 million in 2023, then climbed by 6.77% to $69.6 million in 2024, then gained by 15.5% to $80.4 million in 2025, then jumped by 49.49% to $120.3 million in 2026.
• The last three Total Current Liabilities figures came in at $120.3 million (Q2 2026), $120.0 million (Q1 2026), and $80.4 million (Q4 2025), per Business Quant data.